Nancy Vinh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Dec 18, 2020 By Alex Keown Cidara Therapeutics – Christopher Kurtz was named executive vice president of Technical Operations at Cidara Therapeutics. Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Prior to joining Cidara, Kurtz served as head of commercial API manufacturing at Gilead Sciences. He previously served as vice president, for drug device industrialization at AbbVie, where he led product scale-up and industrialization ...

DGAP-News: Immun ... DGAP-News: Immune Regulation Limited: Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US vom 17.12.2020, 09:00 Uhr Bild: pixabay.com DGAP-News: Immune Regulation Limited / Key word(s): Personnel Immune Regulation Limited: Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US 17.12.2020 / 09:00 The issuer is solely responsible for the content of this announcement. Immune Regulation appoints New Chairman and builds out S...

Immune Regulation Limited Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US DGAP-News: Immune Regulation Limited / Key word(s): Personnel Immune Regulation Limited: Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US 17.12.2020 / 09:00 The issuer is solely responsible for the content of this announcement. Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US (London UK, New Or...

Search jobs 17-Dec-2020 Immune Regulation Appoints New Chairman and Builds Out Senior Management Team with Standout Industry Professionals in the US LONDON, UK and NEW ORLEANS, US, December 17, 2020 / B3C newswire / --Immune Regulation Ltd, a US and UK based clinical stage biotechnology company announced today a series of appointments to build out the Board and leadership team that will work alongside Jonathan Rigby, Group CEO of Immune Regulation, in advancing the development of its first-in-class immune resetting therapies for autoimmune and alle...